{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:53:31Z","timestamp":1784296411840,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["5M-2019-23680287"],"award-info":[{"award-number":["5M-2019-23680287"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:28:31Z","timestamp":1745911711000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography\/Computed Tomography"],"prefix":"10.1016","volume":"9","author":[{"given":"Francesca","family":"Ambrosini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataniele","family":"Piol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Drocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Col","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Martiriggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Celesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Giasotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fornarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvina","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmario","family":"Sambuceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Mantica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.02.012_b0005","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.euo.2025.02.012_b0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00259-023-06490-z","article-title":"The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients","volume":"51","author":"Bauckneht","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.euo.2025.02.012_b0015","first-page":"56","article-title":"A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET\/CT in the initial staging of prostate cancer","volume":"28","author":"A","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.02.012_b0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2018.01.006","article-title":"Efficacy, predictive factors, and prediction nomograms for 68 Ga-labeled prostate-specific membrane antigen\u2013ligand positron-emission tomography\/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy","volume":"73","author":"Rauscher","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.012_b0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00259-019-04505-2","article-title":"Prediction nomogram for 68Ga-PSMA-11 PET\/CT in different clinical settings of PSA failure after radical treatment for prostate cancer","volume":"47","author":"Ceci","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.02.012_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euo.2021.12.002","article-title":"Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen\/positron emission tomography scan in patients with prostate cancer recurrence","volume":"6","author":"Bianchi","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.012_b0035","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.7150\/thno.44584","article-title":"Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68 Ga-PSMA-11-PET","volume":"10","author":"Ferraro","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.euo.2025.02.012_b0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.humpath.2006.11.012","article-title":"Prostate-specific membrane antigen expression as a predictor of prostate cancer progression","volume":"38","author":"Perner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euo.2025.02.012_b0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2967\/jnumed.117.195172","article-title":"Immunohistochemical validation of PSMA expression measured by 68 Ga-PSMA PET\/CT in primary prostate cancer","volume":"59","author":"Woythal","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2025.02.012_b0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3389\/fonc.2018.00623","article-title":"Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis","volume":"8","author":"Hupe","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.02.012_b0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","article-title":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis","volume":"15","author":"Mannweiler","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.euo.2025.02.012_b0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14828","article-title":"Risk of metastatic disease on 68 gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer: 68 Ga-PPSMA PET primary staging prostate cancer","volume":"124","author":"Yaxley","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.02.012_b0065","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/tomography8050205","article-title":"Prostate cancer biochemical recurrence resulted negative on [68Ga]Ga-PSMA-11 but positive on [18F]fluoromethylcholine PET\/CT","volume":"8","author":"Laudicella","year":"2022","journal-title":"Tomography"},{"key":"10.1016\/j.euo.2025.02.012_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-022-03846-1","article-title":"Gene\u2019s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study","volume":"21","author":"Bauckneht","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.euo.2025.02.012_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00345-024-04948-9","article-title":"Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery","volume":"42","author":"Mehring","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.012_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1324631","article-title":"Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection","volume":"14","author":"Droghetti","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.02.012_b0085","series-title":"EAU-EANM-ESTRO-ESUR-ESUP-SIOG guidelines on prostate cancer","author":"Mottet","year":"2022"},{"key":"10.1016\/j.euo.2025.02.012_b0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.012_b0095","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.02.012_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00345-024-04824-6","article-title":"Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients","volume":"42","author":"Ambrosini","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.012_b0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euo.2020.08.003","article-title":"Added clinical value of whole-mount histopathology of radical prostatectomy specimens: a collaborative review","volume":"4","author":"Cimadamore","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.012_b0110","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.02.012_b0115","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-011-1846-5","article-title":"Molecular imaging with 68Ga-SSTR PET\/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours","volume":"38","author":"Kaemmerer","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.02.012_b0120","series-title":"Handbook of inter-rater reliability: the definitive guide to measuring the extent of agreement among raters","author":"Gwet","year":"2014"},{"key":"10.1016\/j.euo.2025.02.012_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.879089","article-title":"Correlation between quantitative PSMA PET parameters and clinical risk factors in non-metastatic primary prostate cancer patients","volume":"12","author":"Zschaeck","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.02.012_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2023.102212","article-title":"Gwet\u2019s AC1 is not a substitute for Cohen\u2019s kappa\u2014a comparison of basic properties","volume":"10","author":"Vach","year":"2023","journal-title":"MethodsX"},{"key":"10.1016\/j.euo.2025.02.012_b0135","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1007\/s00259-021-05501-1","article-title":"What\u2019s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns","volume":"48","author":"R\u00fcschoff","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.02.012_b0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.21241","article-title":"High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer","volume":"71","author":"Minner","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.02.012_b0145","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1038\/s41598-018-22594-1","article-title":"PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis","volume":"8","author":"Bravaccini","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2025.02.012_b0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.euo.2019.03.002","article-title":"There is no way to avoid systematic prostate biopsies in addition to multiparametric magnetic resonance imaging targeted biopsies","volume":"3","author":"Dell\u2019Oglio","year":"2020","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:35:30Z","timestamp":1778898930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2588931125000458"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.012","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}